- Home
- FOLD vs RRR Comparison
FOLD vs RRR Comparison
Compare FOLD & RRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FOLD | RRR |
|---|---|---|
| Founded | 2002 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 3.7B |
| IPO Year | 2007 | 2016 |
Fundamental Metrics
Financial Performance| Metric | FOLD | RRR |
|---|---|---|
| Price | $14.36 | $61.72 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 14 |
| Target Price | $27.56 | ★ $62.14 |
| AVG Volume (30 Days) | ★ 21.4M | 632.3K |
| Earning Date | 02-18-2026 | 02-10-2026 |
| Dividend Yield | N/A | ★ 3.27% |
| EPS Growth | N/A | ★ 15.51 |
| EPS | N/A | ★ 3.14 |
| Revenue | $598,704,000.00 | ★ $1,995,401,000.00 |
| Revenue This Year | $21.49 | $4.23 |
| Revenue Next Year | $18.46 | $3.41 |
| P/E Ratio | ★ N/A | $19.89 |
| Revenue Growth | ★ 21.28 | 4.69 |
| 52 Week Low | $5.51 | $35.09 |
| 52 Week High | $14.36 | $64.69 |
Technical Indicators
Market Signals| Indicator | FOLD | RRR |
|---|---|---|
| Relative Strength Index (RSI) | 89.94 | 51.76 |
| Support Level | $14.26 | $61.33 |
| Resistance Level | $14.35 | $62.60 |
| Average True Range (ATR) | 0.05 | 1.58 |
| MACD | -0.12 | -0.25 |
| Stochastic Oscillator | 100.00 | 32.16 |
Price Performance
Historical ComparisonAbout FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.
About RRR Red Rock Resorts Inc.
Red Rock Resorts Inc along with its subsidiary is a gaming, development and management company that develops and operates strategically-located casino and entertainment properties. Its casino properties are conveniently located throughout the Las Vegas valley and provide its customers a wide variety of entertainment and dining options. The majority of revenue is derived from Casinos.